PLUS1
17.00
0.95 (5.92%)
0.95 (5.92%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.17 | -1.05% | 16.05 | 15.75 | 17.06 | 16.23 | 16.22 | 18:38:37 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 15.78 | 17.00 | 1.22 | 7.18% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,642 | 473,477 | $ 16.30 | $ 7,716,439 | 1,893,565 | 4.47 - 17.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:37:33 | formt | 300 | $ 17.00 | USD |
Protagonist Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 460.11M | 28.67M | 28.03M | $ 231.00k | $ - | -2.99 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Protagonist Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/04/2020 | 07:00 | PR Newswire (US) | Protagonist Therapeutics to Present at the 25th European.. |
| 5/29/2020 | 18:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/29/2020 | 18:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/29/2020 | 18:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/29/2020 | 18:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/29/2020 | 18:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/29/2020 | 18:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.59 | 17.56 | 15.28 | 16.38 | 596,792 | -0.54 | -3.25% |
| 1 Month | 9.84 | 17.84 | 9.00 | 14.90 | 2,882,484 | 6.21 | 63.11% |
| 3 Months | 6.70 | 17.84 | 5.30 | 14.11 | 1,010,183 | 9.35 | 139.55% |
| 6 Months | 7.70 | 17.84 | 5.30 | 12.72 | 595,579 | 8.35 | 108.44% |
| 1 Year | 10.05 | 17.84 | 4.47 | 11.55 | 503,036 | 6.00 | 59.7% |
| 3 Years | 10.54 | 23.97 | 4.47 | 11.35 | 279,756 | 5.51 | 52.28% |
| 5 Years | 12.00 | 26.3598 | 4.47 | 11.60 | 236,748 | 4.05 | 33.75% |
Protagonist Therapeutics Description
| Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. |
